Skip to Content

Lanthanum Carbonate

In some countries, this medicine may only be approved for veterinary use.

In the US, Lanthanum Carbonate (lanthanum carbonate systemic) is a member of the drug class phosphate binders and is used to treat Hyperphosphatemia of Renal Failure.

US matches:

ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Treatment of hyperphosphatemia

Phosphate binder

Chemical Names

Carbonic acid, lantanum(3+) salt(3:2)

Dilantanum tricarbonate

Foreign Name

  • Lanthan carbonat (German)

Generic Names

  • Lanthan(III)-carbonat (IS)
  • Lanthanum sesquicarbonate (IS)
  • Lanthanum Carbonate (OS: USAN)
  • Lanthanum Carbonate Hydrate (OS: JAN)
  • UNII-490D9F069T (IS)

Brand Names

  • Fosrenol
    Fresenius Kabi, Thailand; Hamol, Malaysia; Pratapa Nirmala/Fahrenheit, Indonesia; Shire, Belgium; Shire, Canada; Shire, Hong Kong; Shire, Iceland; Shire, Philippines; Shire, Poland; Shire, Slovenia; Shire, Taiwan; Shire Human Genetic Therapies AB, Portugal; Shire Pharmaceutical, Cyprus
  • Lanthonate
    Micro Labs, India
  • Fosrenol
    Al Pharm, South Africa; Bayer Yakuhin, Japan; Euro Registratie, Netherlands; Medcor, Netherlands; Opopharma, Switzerland; Shire, Australia; Shire, Bulgaria; Shire, Czech Republic; Shire, Germany; Shire, Denmark; Shire, Estonia; Shire, Spain; Shire, Finland; Shire, France; Shire, Greece; Shire, Israel; Shire, Lithuania; Shire, Latvia; Shire, Malta; Shire, Netherlands; Shire, Norway; Shire, Romania; Shire, United States; Shire Human Genetic Therapies, Austria; Shire Pharmaceutical Contracts Ltd., Hungary; Shire Pharmaceuticals, United Kingdom; Shire Sweden, Sweden
  • Foznol
    Shire Italia, Italy; Shire Pharmaceuticals Ireland, Ireland
  • Renalzin (Lanthanum Carbonate and Kaolin (veterinary use))
    Orion Pharma Eläinlääkkeet, Finland


ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.